Publications by authors named "Thomas Verron"

Claim this Profile
E
Evaluation of high-nicotine oral products shows potential to reduce tobacco-related harm by offering satisfying alternatives.
Fiona Chapman, Ruby Morrissey, Simon McDermott, Xavier Cahours, Thomas Verron

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of the impact of myblu electronic nicotine delivery system e-liquid nicotine strength on self-reported measures of dependence.
Ian M Fearon, Ryan G N Seltzer, Trisha L Houser, Andrew Tope, Xavier Cahours, Thomas Verron

Drug Test Anal· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curiosity and intentions to use myblu e-cigarettes and an examination of the 'gateway' theory: Data from cross-sectional nationally representative surveys.
Ian M Fearon, Ryan G N Seltzer, Trisha L Houser, Andrew Tope, Xavier Cahours, Thomas Verron

Drug Test Anal· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu electronic nicotine delivery systems (ENDS).
Paul Morris, Simon McDermott, Fiona Chapman, Thomas Verron, Xavier Cahours

Intern Emerg Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-endpoint analysis of human 3D airway epithelium following repeated exposure to whole electronic vapor product aerosol or cigarette smoke.
Lukasz Czekala, Roman Wieczorek, Liam Simms, Fan Yu, Jessica Budde, Thomas Verron

Curr Res Toxicol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data.
Layla Malt, Thomas Verron, Xavier Cahours, Mengran Guo, Sarah Weaver

Harm Reduct J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers.
Grant O'Connell, John D Pritchard, Chris Prue, Joseph Thompson, Thomas Verron

Intern Emerg Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling of cigarette smoke constituents - From intense to less intense smoking regime.
Thomas Verron, Rémi Julien, Xavier Cahours, Stéphane Colard

Regul Toxicol Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic cigarettes and indoor air quality: a simple approach to modeling potential bystander exposures to nicotine.
Stéphane Colard, Grant O'Connell, Thomas Verron, Xavier Cahours, John D Pritchard

Int J Environ Res Public Health· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some consequences of using cigarette machine smoking regimes with different intensities on smoke yields and their variability.
Stephen W Purkis, Xavier Cahours, Miguel Rey, Beatrice Teillet, Valerie Troude, Thomas Verron

Regul Toxicol Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis